Roche sales increase by 2% (CER) in first quarter with both divisions growing high single digit ex COVID-19. We confirm our outlook for 2024. For more details on our performance, click here ➡️ spkl.io/601342ikf

$ROG $RHHBY #RocheFinancialResults

We are delighted that the FDA has approved our ALK inhibitor for adjuvant use for people with resected ALK-positive early-stage lung cancer, furthering our aim to provide patients with the best chance for cure. spkl.io/601642Bqw
$RHHBY $ROG
#RocheInnovation #Science

Paulo Fontoura discusses the future of #MultipleSclerosis care and how the latest advancements in scientific research are helping to provide new options for people with MS in managing their condition from diagnosis: spkl.io/60174FaCz

#MEDIA
We are pleased to announce that our off-the-shelf bispecific antibody combination showed a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell #lymphoma in a Phase III study.
spkl.io/60124FlLr
$RHHBY

#MEDIA : We are pleased to announce that FDA granted Breakthrough Device Designation of our blood test to support earlier #Alzheimer 's disease diagnosis.
Learn more here: spkl.io/60134FVNt
$ROG $RHHBY

#MyHealthMyRight isn't just a slogan! Roche partners with mothers2mothers Ghana to ensure healthcare access for mothers & children in Ghana. This #WorldHealthDay , join us in building a healthier world! 👉 spkl.io/601540fnb
#HealthForAll #mothers2mothers

#SMAMyWay Champion, Louise, discusses her journey from childhood to adult care while living with spinal muscular atrophy (SMA). Hear her experience and the advice she would give her younger self.

#MyStoryForChange gave voice to hundreds of women in the world to share their health stories.
Learn more about the results and what they uncovered here: spkl.io/601440Dzi

#XProject #TogetherForChange

#MEDIA - We are pleased to announce that Roche received FDA approval for the first molecular test to screen for #malaria in blood donors.
Read more here: spkl.io/601640zDC

$ROG $RHHBY

Exciting news!🎉 Professor Juergen Knoblich The Knoblich Lab, a pioneer in #organoids & neurobiology, joins Roche as the Head of the Institute of Human Biology in #Basel . His expertise will help us accelerate drug development. Institute of Human Biology's future looks bright! #RocheInnovation

Countless women globally confront challenges in healthcare stemming from a pervasive misunderstanding of female health. We've reached out to them, and they told us their stories. Here are the results: spkl.io/60194LLHX #XProject #TogetherForChange #MyStoryForChange

Join our LinkedIn Live on the digital endpoints, on March 21st to hear the insights of Prof Jeffrey Statland from KU Medical Center, Damien Eggenspieler and Paul Strijbos, Neurotech Innovation at Roche. Register here: bit.ly/48fcs5e #DigitalEndpoints #ClinicalTrials

Congrats on the milestone! Roche values strategy & teamwork for global patient innovation. Here's to a century more of healthcare breakthroughs in Belgium! #CloseTheHealthcareGap #Roche100yinBE

#IWD2024 may have passed, but the work to bring about a more equitable future in healthcare is still ahead of us. Learn more about the challenges women face in healthcare and help us close the gaps: spkl.io/60154LMd5

#MyStoryForChange
#TogetherForChange
#InspireInclusion

On #WorldKidneyDay , we're spotlighting our dedication to nephrology. 🌍 Roche is seeking ways to improve kidney health and patient lives. Together, we can make a difference! #Roche #Nephrology #HealthcareInnovation #KidneyHealthforAll

Our shareholders have approved all Board proposals at our AGM. Our goal? Faster patient care. 'Even in a marathon, every minute counts,' says CEO Thomas Schinecker. Find out more here: spkl.io/60124LybA

#HealthcareInnovation #PatientCare